biotech · Melanoma · Psoriasis · PVCT
Provectus Biopharmaceuticals
PROVECTUS BIOPHARMACEUTICALS, INC.
Provectus Biopharmaceuticals is a biotech organization headquartered in Knoxville, USA. It trades on NYSE under ticker PVCT. Primary therapeutic focus areas include Melanoma, Psoriasis, Atopic Dermatitis, Plaque Psoriasi
Knoxville, Tennessee 37932, US HQ
2004 Founded
7 Employees
Public company Type
PVCT · NYSE Ticker
Company details
- Status
- Public
- HQ
- Knoxville, Tennessee 37932, US
- Founded
- 2004
- Employees
- 7
- Programs
- 12
- Drugs
- 5
- Patents
- 29
PV-10 (10% rose bengal disodium)
Phase 2 · small molecule · Melanoma
PV-10 (10% rose bengal disodium) for Melanoma is a Phase 2 program (small_molecule) at PROVECTUS BIOPHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Internal code PV-10-MM-02
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- PROVECTUS BIOPHARMACEUTICALS, INC.
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Melanoma
- Status
- completed
- Trials
- 1